SAGE

Sage Therapeutics
SAGE

Overview Fund Activity
Delisted

SAGE was delisted on the 30th of July, 2025.

Back to rankings

216 hedge funds and large institutions have $2.25B invested in Sage Therapeutics in 2020 Q2 according to their latest regulatory filings, with 46 funds opening new positions, 84 increasing their positions, 55 reducing their positions, and 57 closing their positions.

Holders
216
Holders Change
-13
Holders Change %
-5.68%
% of All Funds
4.44%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.06%
New
46
Increased
84
Reduced
55
Closed
57
Calls
$30.5M
Puts
$21.9M
Net Calls
+$8.54M
Net Calls Change
+$7.53M

Top Buyers

1
D.E. Shaw & Co
1
D.E. Shaw & Co
New York
$88.2M
2
Citadel Advisors
2
Citadel Advisors
Florida
$73.3M
3
CCM
3
Camber Capital Management
Massachusetts
$21.8M
4
BCLSI
4
Bain Capital Life Sciences Investors
Massachusetts
$20.8M
5
BlackRock
5
BlackRock
New York
$132M

Top Sellers

1
Capital International Investors
1
Capital International Investors
California
$18.1M
2
Victory Capital Management
2
Victory Capital Management
Texas
$40.8M
3
Morgan Stanley
3
Morgan Stanley
New York
$6.35M
4
ACA
4
Avoro Capital Advisors
New York
$0
5
EAM
5
Eventide Asset Management
Massachusetts
$0
Name Market Value Shares Shares
Change 		Shares
Change %
Fidelity Investments
1
Fidelity Investments
Massachusetts
$324M 7,787,672 +1,004 +0%
Vanguard Group
2
Vanguard Group
Pennsylvania
$197M 4,733,032 -101,820 -2%
BlackRock
3
BlackRock
New York
$132M 3,185,313 +438,396 +16%
T. Rowe Price Associates
4
T. Rowe Price Associates
Maryland
$117M 2,819,052 -145,256 -5%
D.E. Shaw & Co
5
D.E. Shaw & Co
New York
$88.2M 2,122,156 +1,708,926 +414%
State Street
6
State Street
Massachusetts
$88M 2,117,336 +432,202 +26%
GPP
7
Great Point Partners
Connecticut
$87.4M 2,102,368 +277,889 +15%
Citadel Advisors
8
Citadel Advisors
Florida
$73.3M 1,763,613 +1,155,806 +190%
Invesco
9
Invesco
Georgia
$72.3M 1,738,408 -24,203 -1%
Janus Henderson Group
10
Janus Henderson Group
United Kingdom
$60.7M 1,459,676 +71,881 +5%
BG
11
Bellevue Group
Switzerland
$58.9M 1,415,504 -2,600 -0.2%
JPMorgan Chase & Co
12
JPMorgan Chase & Co
New York
$57.8M 1,390,309 -18,053 -1%
Artisan Partners
13
Artisan Partners
Wisconsin
$50.5M 1,215,429 +341,390 +39%
BC
14
Boxer Capital
California
$45.5M 1,094,000 -438,510 -29%
Victory Capital Management
15
Victory Capital Management
Texas
$40.8M 981,106 -1,211,610 -55%
FCM
16
Farallon Capital Management
California
$35.3M 850,000 +175,000 +26%
Goldman Sachs
17
Goldman Sachs
New York
$33.8M 812,785 +67,197 +9%
Two Sigma Advisers
18
Two Sigma Advisers
New York
$30.4M 731,999 +281,800 +63%
Geode Capital Management
19
Geode Capital Management
Massachusetts
$25.8M 620,400 +25,158 +4%
PAI
20
Palo Alto Investors
California
$23.9M 575,200 -11,474 -2%
Norges Bank
21
Norges Bank
Norway
$23.8M 573,578 +69,347 +14%
Westfield Capital Management
22
Westfield Capital Management
Massachusetts
$23.4M 562,457 +135,765 +32%
CCM
23
Camber Capital Management
Massachusetts
$21.8M 525,000 +525,000 New
BCLSI
24
Bain Capital Life Sciences Investors
Massachusetts
$20.8M 499,100 +499,100 New
UBS AM
25
UBS AM
Illinois
$18.3M 440,846 +182,906 +71%
1
2 3 4 5